A roadmap for developing study endpoints in real-world settings Published August 2020 Citation Baxi, SS, Koontz, L, Mahoney, N, Torres, AZ, Bourla, AB. . Duke-Margolis Center for Health Policy. . https://healthpolicy.duke.edu/sites/default/files/2020-08/Real-World%20Endpoints.pdf Authors:Baxi, SS, Koontz, L, Mahoney, N, Torres, AZ, Bourla, AB Sources:Duke-Margolis Center for Health Policy Share Posted inPublicationsMethodology More publicationsISPORApril 2025Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLCLi X, Jarrett B, Kerr B, et al. Real-world evidencePublication summaryPublicationsMethodologyNon-small cell lung cancerESMO Real-World Data and Digital OncologyFebruary 2025Characterisation of oncology EHR-derived real-world data in the UK, Germany, and JapanAdamson B, Horne E, Xu C, et al.Real-world evidencePublication summaryPublicationsData scienceMethodologyHTA and market accessGynecologic OncologyDecember 2025Comparative outcomes of nab-paclitaxel and paclitaxel in platinum-resistant ovarian cancer (COMPASS)Shahin M, Mathur R, Parthan A, et al.Real-world evidencePublication summaryPublicationsComparative effectivenessOvarian cancer